InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kullman Ellen Jamison, Director. Officer active across 2 companies, notably AMGEN INC. Aggregated, 12 filings have been published. The latest transaction was disclosed on 17 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
0855 shares0
Common Stock
SEC:0001127602-22-015179:0·
0140.741 shares0
Common Stock
SEC:0001127602-22-013336:0·
0152.033 shares0
Common Stock
SEC:0001127602-21-028760·
0152.033 shares0
Common Stock
SEC:0001127602-21-028760:0·
03,123 shares0
Class C Common Stock
SEC:0001123292-21-001338·
03,123 shares0
Class C Common Stock
SEC:0001123292-21-001338:0·
0282.425 shares0
Common Stock
SEC:0001127602-21-023489·
0282.425 shares0
Common Stock
SEC:0001127602-21-023489:0·
0837 shares0
Common Stock
SEC:0001127602-21-017468·
0837 shares0
Common Stock
SEC:0001127602-21-017468:0·
0135.62 shares0
Common Stock
SEC:0001127602-21-015043·
0135.62 shares0
Common Stock
SEC:0001127602-21-015043:0·
12 of 12 declarations
About Kullman Ellen Jamison
Ellen Jamison Kullman is a Director at Amgen Inc. and Dell Technologies Inc. In this role, she participates in the governance of these companies and strategic decision-making. Ellen brings expertise in biotechnology and information technology, enabling her to contribute to overseeing operations and guiding these companies' strategic direction. Her commitment to innovation and efficiency is essential for their success.
